New Brunswick expands use of biosimilars to improve sustainability of public drug plans
The New Brunswick government is following the lead of other jurisdictions and expanding its use of biosimilar drugs to improve the sustainability of public drug plans, Health Minister Dorothy Shephard announced Wednesday.
Social Sharing
About 3,000 patients taking originator biologic drugs have until Nov. 30 to switch to biosimilar version
Posted: Apr 22, 2021 9:00 AM AT | Last Updated: April 22
Health Minister Dorothy Shephard said New Brunswick has been a leader in providing residents with coverage for new drugs in a timely manner.(Ed Hunter/CBC)